Piperacillin and Tazobactam
- Product NDC
- 22607-679
- 11-digit product format
- 226070679
- Labeler code
- 22607
- Product ID
- 22607-679_68e829fe-50ce-4640-908b-2ec4b6ffbe9a
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- piperacillin sodium and tazobactam sodium
- Dosage form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Mitim S.r.l.
- Application
- ANDA207146
- Marketing category
- ANDA
- Marketing start
- 2017-03-20
- Marketing end
- 0000-00-00
- Substance
- PIPERACILLIN SODIUM; TAZOBACTAM SODIUM
- Active strength
- 36 g/180mL; g/180mL
- Pharmacologic classes
- Penicillin-class Antibacterial [EPC],Penicillins [CS],beta Lactamase Inhibitors [MoA],beta Lactamase Inhibitor [EPC]
- NDC exclude flag
- E
- Listing certified through
- 2018-12-31
- Current FDA listing
- Historical FDA.report record
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Code | Status | Archive | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | bbbc9f937eca… | 946b9c97cf81… | |
| 2025-03-01 13:19 UTC · source 2025-02-28 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | bbbc9f937eca… | 946b9c97cf81… |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f268b84574a6… | 26285f5ac5df… | |
| 2025-02-27 05:24 UTC · source 2025-02-26 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f268b84574a6… | 26285f5ac5df… |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f764e8902f78… | 92046438deef… | |
| 2025-02-01 13:13 UTC · source 2025-01-31 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | f764e8902f78… | 92046438deef… |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 68b1e3bced9e… | 98a755eb8bc6… | |
| 2025-01-20 13:05 UTC · source 2025-01-17 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 68b1e3bced9e… | 98a755eb8bc6… |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… | |
| 2024-11-29 20:42 UTC · source 2024-11-29 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 05c55d027831… | ca05dca9dc4c… |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… | |
| 2024-11-09 02:36 UTC · source 2024-11-08 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 48b4f40e6753… | c7c7a00d2afa… |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… | |
| 2024-10-09 02:27 UTC · source 2024-10-08 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 27f29a85d7e4… | 1372111e901f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 8d62ce987f31… | 9fe9ef23e30d… |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… | |
| 2024-05-28 21:11 UTC · source 2024-05-28 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | d1e113ab4d42… | 063ee3eb0a1d… |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished product | product | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… | |
| 2024-05-15 03:51 UTC · source 2024-05-14 | unfinished package | package | 22607-679-01 | UNFINISHED | Active or certified unfinished drug listing | unfinished / ndc_unfinished.zip | 50b4072663b7… | eae3003ed65e… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | I | Inactivated by FDA | excluded / ndc_excluded.zip | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 22607-679-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | I | Inactivated by FDA | excluded / ndc_excluded.zip | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 22607-679-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | I | Inactivated by FDA | excluded / ndc_excluded.zip | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 22607-679-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 22607-679-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 22607-679-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 22607-679-01 | I | Inactivated by FDA | excluded / ndc_excluded.zip | 9bebd1f3094a… | 5416666fcb17… |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded product | product | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 110d247fa046… | a55b01930146… | |
| 2019-12-08 06:16 UTC · source 2019-12-05 | excluded package | package | 22607-679-01 | E | Excluded after deficient or non-compliant submission was not corrected | excluded / ndc_excluded.zip | 110d247fa046… | a55b01930146… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207146-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207146-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207146-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207146-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207146-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207146-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207146-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207146-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207146-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207146-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207146-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207146-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207146-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207146-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207146-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207146-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207146-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207146-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207146-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207146-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207146-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207146-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207146-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207146-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207146-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207146-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A207146-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A207146-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A207146-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A207146-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207146-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A207146-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A207146-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207146-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207146-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207146-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207146-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207146-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207146-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207146-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207146-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207146-001 | AP | 1 | e64feba35796… |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 22607-679-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9cf-fd6d-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use PIPERACILLIN AND TAZOBACTAM FOR INJECTION safely and effectively. See full prescribing information for PIPERACILLIN AND TAZOBACTAM FOR INJECTION. PIPERACILLIN and TAZOBACTAM for Injection, for intravenous use Initial U.S. approval: 1993 |